Hepatitis E infection can be effectively managed in people with ANCA-associated vasculitis (AAV) by pausing immunosuppressive therapy, though patients…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with ANCA-associated vasculitis (AAV) are at an increased risk of experiencing cardiovascular problems, such as a stroke, according…
Two cases of teen boys with ANCA-associated vasculitis (AAV) that caused heart problems — a very rare manifestation of…
After approximately $3.7 billion in acquisitions, Amgen will own the rights to Tavneos (avacopan), an approved oral therapy developed by…
Measuring the blood levels of a protein called BAFF could help predict the chances of remission after induction treatment with…
Levels of five small RNA molecules were found to be highly elevated in extracellular vesicles — small packets of cellular…
Health Canada has approved the oral medicine Tavneos (avacopan) as an add-on therapy to treat adults with severe…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
A team of scientists in Europe has developed a novel mouse model of the type of kidney damage that commonly…
Levels of a protein called KL-6 are elevated in ANCA-associated vasculitis (AAV) patients who have interstitial lung diseases, indicating…